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Presenilin 1 (PS1) and Presenilin 2 (PS2) are predominantly known as the catalytic
subunits of the γ-secretase complex that generates the amyloid-β (Aβ) peptide, the
major constituent of the senile plaques found in the brain of Alzheimer’s disease
(AD) patients. Apart from their role in γ-secretase activity, a growing number of
cellular functions have been recently attributed to PSs. Notably, PSs were found to
be enriched in mitochondria-associated membranes (MAMs) where mitochondria and
endoplasmic reticulum (ER) interact. PS2 was more specifically reported to regulate
calcium shuttling between these two organelles by controlling the formation of functional
MAMs. We have previously demonstrated in mouse embryonic fibroblasts (MEF) an
altered mitochondrial morphology along with reduced mitochondrial respiration and
increased glycolysis in PS2-deficient cells (PS2KO). This phenotype was restored by the
stable re-expression of human PS2. Still, all these results were obtained in immortalized
cells, and one bottom-line question is to know whether these observations hold true
in central nervous system (CNS) cells. To that end, we carried out primary cultures of
PS1 knockdown (KD), PS2KO, and PS1KD/PS2KO (PSdKO) neurons and astrocytes.
They were obtained from the same litter by crossing PS2 heterozygous; PS1 floxed
(PS2+/−; PS1flox/flox) animals. Genetic downregulation of PS1 was achieved by lentiviral
expression of the Cre recombinase in primary cultures. Strikingly, we did not observe
any mitochondrial phenotype in PS1KD, PS2KO, or PSdKO primary cultures in basal
conditions. Mitochondrial respiration and membrane potential were similar in all models,
as were the glycolytic flux and NAD+/NADH ratio. Likewise, mitochondrial morphology
and content was unaltered by PS expression. We further investigated the differences
between results we obtained here in primary nerve cells and those previously reported
in MEF cell lines by analyzing PS2KO primary fibroblasts. We found no mitochondrial
dysfunction in this model, in line with observations in PS2KO primary neurons and
astrocytes. Together, our results indicate that the mitochondrial phenotype observed
in immortalized PS2-deficient cell lines cannot be extrapolated to primary neurons,
astrocytes, and even to primary fibroblasts. The PS-dependent mitochondrial phenotype
reported so far might therefore be the consequence of a cell immortalization process and
should be critically reconsidered regarding its relevance to AD.
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INTRODUCTION
Alzheimer’s disease (AD) is the most prevailing age-related
neurodegenerative disease. Its cost and impending rise owed
to societal aging makes it a major social concern and a
critical public health burden. This pathology is characterized
by the progressive spreading of two typical lesions in the
brain: senile plaques and neurofibrillary tangles (NFTs), that
are extracellular deposits of the amyloid-β peptide (Aβ) and
intracellular aggregates of hyperphosphorylated tau protein,
respectively (Serrano-Pozo et al., 2011). The most admitted
comprehensive hypothesis for the onset and development of
AD is the amyloid cascade hypothesis (ACH) (Hardy, 2006).
It postulates that changes in Aβ production, accumulation, or
clearance are triggering events that induce the formation of NFTs
eventually leading to neurodegeneration and clinical symptoms.
Many efforts have been undertaken to better understand the
pathological processes responsible for the altered production of
Aβ. They led to the identification of the Amyloid Precursor
Protein (APP), and the Presenilin proteins (PS1 and PS2) that
are the catalytic subunits of the γ-secretase that releases Aβ
upon amyloidogenic processing of APP (Goate et al., 1991;
Rogaev et al., 1995; Sherrington et al., 1995). However, clinical
trials targeting the amyloid pathology have failed so far to
improve cognitive deficits, even though they reduce the amyloid
load under certain conditions (Ceyzeriat et al., 2020). Amyloid
deposition appears to take place very early in pre-clinical stages
and might be associated to brain dysfunctions that appear prior
to clinical symptoms. Metabolic aspects of the pathology are
widely studied in that context. For instance, the 18F-FDG-PET
scan is an established imaging standard for neuronal dysfunction
in the diagnostic workup of AD-patients (Mosconi et al., 2010;
Herholz, 2012; Shivamurthy et al., 2015). It was used to evidence
that hypometabolism and brain atrophy appear before clinical
symptoms in patients.
Mitochondria play a central role in cellular metabolism, and
mitochondrial function is known to be particularly affected in the
disease (Garcia-Escudero et al., 2013). Several studies have put
forth a “mitochondrial cascade hypothesis” (Swerdlow and Khan,
2004; Stanga et al., 2020), according to which mitochondrial
alterations are capable of initiating compensatory events that
would result in the histopathological sequence of AD, including
an increased production of the amyloid-β (Aβ) peptide, and thus
they can be considered as an upstream event in the development
of the pathology. Alternatively, mitochondrial dysfunction has
also rather been suggested as a consequence of pathological
processes such as amyloid deposition (Pagani and Eckert, 2011;
Swerdlow et al., 2014; Swerdlow, 2018). Despite this controversy,
Abbreviations: 19 , mitochondrial membrane potential; 2R2, PS2
knockout rescued PS2; CI-CV, complexes I-V; Ct, control; DTAB,
dodecyltrimethylammonium bromide; ETC, electron transport chain;
FCCP, carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone; GFAP, glial-
fibrillary acidic protein; MAM, mitochondria-associated membranes; MAP-2,
microtubule-associated protein 2; MEF, mouse embryonic fibroblasts; MiNA,
mitochondrial network analysis; OCR, oxygen consumption rate; OXPHOS,
oxidative phosphorylation; PS, presenilin; ROS, reactive oxygen species; TMRM,
tetramethylrhodamine methyl ester.
there is little doubt that mitochondrial dysfunction contributes
to AD pathogenesis, as evidenced in animal models of AD
(Yao et al., 2009; Dixit et al., 2017; Long and Holtzman, 2019)
and samples from AD patients (Wang et al., 2009; Martin-
Maestro et al., 2017; Adav et al., 2019). Major consequences of
mitochondrial dysfunction such as increased Reactive Oxygen
Species (ROS) production (Dixit et al., 2017), impaired balance
of fusion/fission with altered morphology (Wang et al., 2009),
decreased oxidative capacity and decreased motility (Correia
et al., 2016) are described in AD pathogenesis.
Mitochondrial alterations found in AD have been associated
to functional changes of the major AD proteins, namely APP,
Tau, and PSs (Garcia-Escudero et al., 2013). Only Presenilin 1
and 2 (PS1 and PS2) were yet clearly shown to be involved
in mitochondrial function. PS1 and PS2 are encoded by two
homologous genes, PSEN1 and PSEN2, respectively. Mutations
in PSEN genes are responsible for the majority of inherited
AD cases (Hardy, 2006). Apart from their involvement in
Aβ production (as the catalytic subunits of the γ-secretase),
functions attributed to PSs can be divided into two categories: γ-
secretase-dependent or γ-secretase-independent (Vetrivel et al.,
2006; Zhang et al., 2013). The γ-secretase independent functions
of PSs are known to be involved in synaptic transmission,
endosome-lysosome trafficking, Wnt signaling, and calcium
homeostasis. The involvement of PSs in calcium homeostasis
has been particularly investigated. PSs could interact with
Inositol trisphosphate receptor (IP3R) (Cheung et al., 2008),
sarco-/endoplasmic reticulum (ER) Ca2+ ATPase (SERCA), or
Ryanodine receptors (RyR) (Green et al., 2008; Wu et al.,
2013) to regulate intracellular calcium signaling. PSs were also
suggested to directly act as a low-conductance, passive ER
Ca2+ channel (Nelson et al., 2007). Finally, PSs could also
regulate the calcium crosstalk between the mitochondria and
the ER by regulating their apposition through a particular
domain called mitochondria-associated membranes (MAMs)
(Filadi et al., 2016). Indeed, studies have shown that PSs are
enriched in MAMs, which are lipid-raft-like structures. MAMs
are considered as functional compartments (Area-Gomez et al.,
2009) due to their implication in cellular pathways such as
inflammation, mitophagy, and lipid production (Filadi et al.,
2017). PS2 was found to physically interact with Mitofusin 2
to regulate MAMs organization and calcium shuttling in mouse
embryonic fibroblasts (MEF) (Filadi et al., 2016). Disruption
of this interaction and of the consecutive calcium crosstalk
was reported in the SH-SY5Y cell line transfected with siRNA
targeting PS2 (Zampese et al., 2011). Importantly, impaired
calcium influx from the ER to mitochondria is implicated in the
regulation of the oxidative phosphorylation (OXPHOS) and can
lead to mitochondrial defects. Using MEF cell lines, we observed
an altered mitochondrial phenotype related to the absence of
PS2 and not PS1 (Contino et al., 2017). PS2 deficiency results
in defective mitochondrial cristae correlated to an impaired
OXPHOS capacity and a modified redox state (NAD+/NADH
ratio). This was compensated by an increased glycolytic capacity,
sustaining a stable ADP/ATP ratio. Together with other studies
(Wang et al., 2009; Pagani and Eckert, 2011; Correia et al., 2016;
Dixit et al., 2017), this led to the hypothesis that PS-dependent
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mitochondrial dysfunction could represent a major pathway in
AD pathogenesis.
In this context, we investigated for the first timemitochondrial
activity in primary cultures of neurons and astrocytes, which are
more relevant to AD than immortalized cells. We performed
primary cultures of cells expressing both PSs (wild-type,
WT), one of them (PS single-knockdown/knockout, referred
to as PS1KD and PS2KO), or none (combined PS1KD-
PS2KO, referred to as PSdKO). Our aim was to investigate
(i) if mitochondrial-related deficits appear in the absence
of PSs in these cells and, if so, (ii) to identify which PS
is involved in this phenotype and the possible mechanisms
underpinning mitochondrial dysfunction in neurons and/or
astrocytes. Surprisingly, we did not find any metabolic deficit in
the different PS knockdown/knockout primary nerve cells, even
in the absence of both PSs (PSdKO). Likewise, mitochondrial
morphology and content were not altered in PS2KO primary
neurons, contrary to what was observed in PS2-deficient MEF
cell lines (Contino et al., 2017). We further studied the
mitochondrial activity in PS2KO primary MEF and did not
observe any mitochondrial defect. The obtained evidence leads
us to conclude that PS-dependent mitochondrial alterations
observed in immortalized cells may provide information about
PS-dependent cancer processes, but give no straightforward
indication about mitochondrial dysfunction in AD.
MATERIALS AND METHODS
Animal Models
Presenilin 2 knockout (KO) (#005617) (Herreman et al., 1999)
and Presenilin 1 floxed (#004825) (Yu et al., 2000) mice,
both in a C57BL/6 background, were obtained from Jackson
Laboratories (Bar Harbor, USA). All animal procedures and
experiments were approved and performed in agreement with the
UCLouvain animal care committee’s regulations (code number
2016/UCL/MD/016). Animals were housed on a 12 h light/dark
cycle in a standard animal care facility with access to water and
food ad libitum.
For primary cell cultures, generation of the different genotypes
in the same litter was obtained from crossing PS2 heterozygous
and PS1 floxed (PS2+/−; PS1flox/flox) animals followed or not by
viral transduction. Indeed, PSEN1 gene deletion was achieved
by viral transduction of Cre recombinase in floxed PS1 primary
cultures. Lentivirus expressing GFP (mock control) or CRE-
GFP were used for transduction at DIV1 (one day of in
vitro culture) for neurons and DIV17 for astrocytes. Following
genotyping and infection we could obtain in the same litter:
control non-infected Ct (PS2+/+; PS1flox/flox, non-infected),
PS2KO (PS2−/−; PS1flox/flox, non-infected); control infected
named Mock (PS2+/+; PS1flox/flox, infected with GFP); PS1KD
(PS2+/+; PS1flox/flox, infected with CRE-GFP); and PSdKO
(PS2−/−; PS1flox/flox, infected with CRE-GFP).
Primary Neuronal Cultures
Primary cultures of neurons were performed as previously
described (Opsomer et al., 2020) on E17mouse embryos. Cortices
and hippocampi were isolated by dissection on ice cold HBSS
(Thermo Fisher Scientific, Waltham, USA) and meninges were
removed. Tissues were then dissociated by pipetting up and down
15 times with a glass pipette in HBSS glucose 5mM medium.
Dissociation was repeated 10 times with a flame-narrowed
glass pipette. After sedimentation for 5min, the supernatant
containing the neurons was settled on a bed of 4ml of Fetal
Bovine Serum (FBS) and centrifuged at 1,000× g for 10min. The
pellet was resuspended in Neurobasal R© medium enriched with
1mML-glutamine, 5mMglucose, and 2% v/v B-27 R© supplement
medium. Cells were plated at 200,000 cells/cm2 on pre-coated
poly-L-lysine dishes and cultured (37◦C, 5% CO2 and humidified
atmosphere). Half media changes were performed every 2 days
and neurons were cultured for 11 days (DIV11) before being
utilized for experiments. To get PS1KD and PSdKO, neurons
were infected at DIV1 and all media were changed at DIV2.
Primary Astrocyte Cultures
For primary astrocyte cultures, the brains of mouse pups aged
2 days were dissected to isolate cortices on ice cold HBSS.
Tissues were triturated 15 times with a glass pipette and 10 times
with a flame-narrowed glass pipette. Tubes were centrifuged at
1,000 × g for 5min. Pellets were resuspended in HBSS and
centrifuged at 1,700 × g for 20min on a 30% Percoll gradient.
Astrocytes were collected from the interphase, washed in 10ml
of HBSS, and centrifuged for 5min at 1,500 × g. Pellets were
resuspended and plated in DMEM-glutaMAX medium (Thermo
Fisher Scientific, Waltham, USA) supplemented with 10% FBS
(Biowest, Nuaillé, France), 50 mg/ml penicillin–streptomycin,
and 50 mg/ml fungizone. Cells were left to proliferate in flasks for
15 days at 37◦C and 5% CO2, and media were changed every 4–
5 days. After 15 days, astrocytes were plated and further cultured
inDMEM-glutaMAXwith 10% FBS. Two days later, transduction
with lentivirus was achieved when necessary and differentiation
was induced by reducing the concentration of FBS to 3% for 7
days before performing experiments.
Primary and Immortalized Mouse
Embryonic Fibroblasts (MEF)
ImmortalizedMEFwere cultured as previously described (Stanga
et al., 2018). Primary cultures of MEF were performed on E16
embryos. Chest skin was isolated on ice and then grinded into
pieces with a blade. These pieces were dissociated and incubated
twice at 37◦C for 10min in trypsin (Life Technologies, Carlsbad,
USA). DMEM low glucose (5.5mM) (Sigma-Aldrich, St Louis,
USA) enriched with 10% FBS and 1% pen/strep was added for
an incubation of 5min at room temperature (RT). Supernatants
were collected and centrifuged at 1,000 × g for 5min at RT.
Pellets were resuspended in 10ml of DMEM medium and
plated in petri dishes. Once at confluence, cells were plated
for experiments.
Lentiviral Particles
Lentiviral particles expressing CRE recombinase were used
to delete floxed PSEN1. Plasmids pCMV-GFP (Mock) and
pCMV-CRE-GFP for lentiviral production were purchased from
Cellomics Technology (Halethorpe, USA). Amplification and
purification of the different plasmids were performed using
Frontiers in Neuroscience | www.frontiersin.org 3 January 2021 | Volume 14 | Article 586108
Contino et al. Presenilin-Deficient Mitochondrial Phenotypes
the Plasmid Midi kit (Qiagen, Hilden, Germany). Lentiviral
production was carried out by transfecting HEK293-T cells
in 10 cm dishes (2 × 106 cells/dish) with CRE-GFP or
GFP vectors, pMD2.G (Addgene#12259), and pCMV-dR8.2
(Addgene#12263). At 48 h after transfection, cells were harvested
by flushing with the medium and centrifuged at 1,500 × g for
10min at 4◦C. The supernatant was filtered with Acrodisc R©
0.45µm filters (Pall, NYC, USA). Then, 1/3 (v/v) of LentiXTM
Concentrator reagent (Clontech, Mountain View, USA) was
added and incubated overnight (o/n). After centrifugation at
1,500 × g for 45min at 4◦C, the pellet was resuspended in 20
µl per dish of DMEM without serum and stored at −80◦C; 10
µl of concentrated virus was used to infect 1,600,000 neurons or
300,000 astrocytes.
Western Blotting (WB)
WB was performed on cell lysates obtained by harvesting cells
with lysis buffer (Tris 125mMpH 6.8, 4% sodium dodecyl sulfate,
20% glycerol) with Complete Protease Inhibitor Cocktail (Roche,
Basel, Switzerland) and sonicating, as previously described
(Stanga et al., 2016). Protein concentration was determined using
the BCA Protein assay kit (Pierce, Rockford, USA). Then, 15
µg of total proteins diluted in lysis buffer with NuPAGE R© LDS
Sample Buffer and 50mM DTT was heated at 70◦C (except for
the detection of OXPHOS subunits, heated at 37◦C). Samples
were loaded and separated onto NuPAGE R© 4–12% Bis-Tris gel
(Life Technologies, Carlsbad, USA) with a NuPAGE R© MES SDS
running buffer (Life Technologies, Carlsbad, USA). Proteins were
then transferred onto an AmershamTM nitrocellulose membrane
(Little Chalfont, UK) with NuPAGE R© transfer buffer (Life
Technologies, Carlsbad, USA) for 2 h at 30V. After blocking
with non-fat dry milk (Darmstadt, Germany) (5% in PBS and
0.05% Tween-20) for a minimum of 30min, the membrane was
incubated o/n with the primary antibody diluted in PBS 0.05%
Tween. Secondary antibody coupled to horse radish peroxidase
was incubated 1 h at RT. Membranes were detected using ECL
PerkinElmer R© (Waltham, USA). ImageJ software was used for
densitometric analysis of the different immunoreactive bands.
Antibodies used and their dilutions are the following: Anti-
Actin (1:3,000; Abcam, Cambridge, United Kingdom); Anti-
APP C-ter (1:2,500; generous gift of N. Sergeant, INSERM
U422, Lille, France); Anti-DRP1 (1:1,000; Cell Signaling,
Danvers, USA); Anti-mouse (1:10,000; GE Healthcare, Little
Chalfont, United Kingdom); Anti-OPA1 (1:1,000; Cell Signaling,
Danvers, USA); Anti-TIM23 (1:500; Santa Cruz, California,
USA); Anti-OXPHOS Cocktail (1:1,000; Abcam, Cambridge,
United Kingdom); Anti-Presenilin 1 (1:1,000; Cell Signaling,
Danvers, USA); Anti-Presenilin 2 (1:1,000; Cell Signaling,
Danvers, USA); Anti-rabbit (1:10,000; GE Healthcare, Little
Chalfont, United Kingdom); Anti-TOM20 (1:1,000; Proteintech,
Rosemont, USA); Anti-Tubulin (1:3,000, Abcam, Cambridge,
United Kingdom).
Immunocytochemistry (ICC)
ICC were performed as previously described (Hage et al.,
2014). Cells were seeded on pre-coated poly-L-lysine
coverslips in 24 well plates at the density of 200,000/well
for neurons or 50,000/well for astrocytes. Cells were fixed with
PBS/paraformaldehyde 4% for 10min and rinsed three times for
5min with PBS. Cells were then permeabilized with a solution
of PBS/Triton 0.3% for 30min and non-specific sites were
blocked with PBS/Triton 0.3%/FBS 5% for 30min. Primary
antibodies diluted in the blocking solution were incubated
o/n at 4◦C. After 3 washes of 10min with PBS, cells were
incubated with DAPI (1:2,000; Sigma-Aldrich, St Louis, USA)
and secondary antibodies diluted in the blocking solution.
Dilutions of the antibodies were as follows: chicken anti-glial-
fibrillary acidic protein (GFAP2; 1:1,1000; Abcam, Cambridge,
United Kingdom); mouse anti-microtubule associated protein
(MAP2; 1:1,000; Sigma-Aldrich, St Louis, USA); rabbit anti-
TOM20 (1:500, Proteintech, Rosemont, USA); Alexa 488
anti-rabbit (1:500; Life Technologies, Carlsbad, USA); Alexa 568
anti-mouse (1:500; Life Technologies, Carlsbad, USA); Alexa 647
anti-chicken (1:500; Life Technologies, Carlsbad, USA).
To characterize neuronal and astrocyte general morphology,
images from MAP2 and GFAP stained-cells were acquired on
EVOS FL Auto microscope (Invitrogen) with RFP (Alexa Fluor
554), and CY5 (Alexa Fluor 647) EVOS LED light cubes and
analyzed with ImageJ software.
To evaluatemitochondrial morphology after TOM20 staining,
samples were examined by confocal microscopy using a confocal
server spinning disc Zeiss platform equipped with a ×100
objective. For each image, z-stacks were taken from the
entire three-dimensional structure and the maximum intensity
projection was obtained in ImageJ.
In silico Analysis of Mitochondrial
Morphology
Morphological analysis of mitochondria was performed in silico
using a plug-in of ImageJ, the toolset MiNA (Mitochondrial
Network Analysis) (Valente et al., 2017). MiNA allows semi-
automated analysis and consists in images’ preprocessing,
to ensure quality, conversion to binary image, and in the
production of the final skeleton for the quantitative analysis, as
previously described (Calabrese et al., 2020). Briefly,






Mitochondrial Membrane Potential (19)
Fluorescent cationic probe tetramethylrhodamine methyl ester
(TMRM) (Sigma-Aldrich, St. Louis, USA) was used to evaluate
the 19 . As a control, we used the uncoupling agent Carbonyl
cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) (Sigma-
Aldrich, St. Louis, USA). Cells were plated in 96-well plates
at a density of 60,000/well for neurons or 15,000/well for
astrocytes. Cells were incubated for 30min at 37◦C with TMRM
(30 nM) with or without FCCP (10µM) diluted in KREBS
medium. Cells were then washed with KREBS solution and
fluorescence was read with the plate reader VICTOR R© Multilabel
Plate Reader (PerkinElmer). Data were normalized to the total
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amount of protein measured by the Bradford assay kit (Bio-Rad
Laboratories, California, USA).
Mitochondrial Oxygen Consumption
Oxygen consumption rate (OCR) was measured with the
Seahorse XF96 bioenergetic analyzer (Seahorse Bioscience;
Massachusetts, USA). Cells were seeded in a Seahorse 96-well
plate at different densities (60,000/well for neurons, 15,000/well
for astrocytes, or 20,000/well for MEF). To analyze the effect of
the inhibition of γ-secretase activity on OCR, cells were treated
with N-[N-(3,5-difluorophenacetyl)-L-alanyl]-sphenylglycine t-
butyl ester (DAPT) (Calbiochem, Camarillo, CA, USA) 24 h
before performing the experiment. Once differentiation was
completed, the medium was exchanged with the conditional
medium (culture medium without sodium bicarbonate and
FBS) and incubated without CO2 at 37
◦C for 1 h. Inhibitors
targeting the different mitochondrial complexes (Cell Mito Stress
Test kit, Seahorse Bioscience) were added automatically and
sequentially to the cells during the experiment to measure the
basal respiration, the coupling, and the spare respiratory capacity.
The sequence of the inhibitors used was: Oligomycin (1µM);
FCCP (0.5µM for neurons and 1µM for astrocytes and MEF);
Rotenone and antimycin A (0.5µM). Results were normalized to
the total amount of protein measured by the Bradford assay kit
(Bio-Rad Laboratories, California, USA).
NAD+/NADH Ratio
NAD+/NADH ratio was measured with the bioluminescent
NAD+/NADH-Glo assay kit (Promega, Wisconsin, USA)
according the manufacturer’s instructions. Cells were seeded
in a 96-well plate at different densities (60,000/well for
neurons, 10,000/well for astrocytes or 20,000/well for MEF).
Once the differentiation was completed, cells were rinsed
with PBS and then lysed with the basis solution 1 %
dodecyltrimethylammonium bromide (DTAB). Samples were
split for a basic or acid treatment and were heated at
60◦C for 15min. The reduced form was decomposed in
the acidic solution and the oxidized form was selectively
decomposed in the basic solution. After neutralization, samples
were mixed with NAD+/NADH-GloTM detection reagent and
incubated for 45min to induce reaction. Luminescence was
read on the GloMax R© 96-well plate luminometer (Promega,
Wisconsin, USA).
Glycolytic Flux
Glycolytic rate was analyzed by the measurement of the
detritiation rate of [3-3H] glucose as previously described
(Contino et al., 2017). Briefly, cells were seeded in a 12-
well plate at density of 800,000/well for neurons, 100,000/well
for astrocytes, or 200,000/well for MEF. Tritiated glucose (0.2
µCi/ml; Perkin-Elmer; Massachusetts, USA) was added to the
medium (including 5.5mM glucose) for 30min. After medium
collection, the tritiated water resulting from detritiated glucose
was separated from the non-transported tritiated glucose by
column chromatography and measured with the Tri Carb
2,810 liquid scintillation analyzer (Perkin Elmer; Massachusetts,
USA) as described previously (Marsin et al., 2002). Data were
normalized to the total amount of protein measured by BCA
assay (Thermo Scientific, Rockford, USA).
ATP Level
ATP level was measured with the bioluminescent ATPlite R© assay
kit (Promega, Wisconsin, USA) according the manufacturer’s
instructions. Cells were seeded in a 96-well plate at a density
of 60,000/well for neurons or 10,000/well for astrocytes. On the
day of the experiment, medium was replaced by 75 µl of fresh
medium for 30min at room temperature. Then, 75 µl of kit’s
solution was added and after 10min of incubation, luminescence
was read on the GloMax R© 96-well plate luminometer (Promega,
Wisconsin, USA).
RT-qPCR Quantification of Mitochondrial
DNA Content
Relative mitochondrial DNA (mtDNA) content was quantified
from isolated total DNA as previously described (Missios
et al., 2014). Briefly, neurons were digested with proteinase
K (100µg/ml) in lysis buffer [100mM NaCl, 100mM
Tris–HCl (pH 8.0), 1mM EDTA, (pH 8.0) and 1% (w/v)
SDS] at 50 ◦C o/n and genomic DNA was purified with
phenol/chloroform method. Real-time quantitative polymerase
chain reaction (RT-qPCR) was performed using different
primer pairs to detect the mitochondrial genes Cyt-b and
Nd1, and the nuclear gene H19. The relative mitochondrial
DNA content was calculated by the 11Ct method. Previously
described primers (Ferrara-Romeo et al., 2020) were used




H19-F 5′-GTACCCACCTGTCGTCC-3′, H19-R 5′-
GTCCACGAGACCAATGACTG-3′.
Statistical Analysis
Number of samples are indicated in figure legends with “n =”
and number of independent experiments with “N =.” GraphPad
Prism software (GraphPad Software, La Jolla, CA, USA) was
used to analyze the data and perform the statistical analyses.
Normality was assessed with Shapiro Wilk test (GraphPad
Prism). Parametric test (Student’s t-test, ANOVA and Tukey’s
multiple comparison test) was applied if the data followed normal
distribution. Otherwise, non-parametric test (Mann-Whitney
test, Kruskal-Wallis and Dunn’s multiple comparison test) was
used. Significance is indicated as: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p <
0.001, ∗∗∗∗p < 0.0001.
RESULTS
Generation of PS1KD, PS2KO, PSdKO
Primary Nerve Cells and Characterization
of the Primary Cultures
Metabolic analyses were performed on primary neurons and
astrocytes produced at embryonic day 17 (E17) and at postnatal
day 2 (P2), respectively. Neurons were cultured for 1 day
(DIV1) and astrocytes for 17 days (DIV17) prior to lentiviral
Frontiers in Neuroscience | www.frontiersin.org 5 January 2021 | Volume 14 | Article 586108
Contino et al. Presenilin-Deficient Mitochondrial Phenotypes
transduction and were further maintained in culture until
DIV11 for neurons and DIV24 for astrocytes. The experimental
workflow is shown in Figure 1A. The different culture times
(DIV) were chosen in order to obtain differentiated and
active primary neurons and astrocytes (Schildge et al., 2013;
Charlesworth et al., 2015). Our previous studies indicated that
under these culture conditions, neurons acquire properties of
differentiated neurons from DIV7 on (Opsomer et al., 2020) and
that the spontaneous calcium oscillation of a functional neuronal
network are readily observed at DIV10 (Santos et al., 2009,
2010). Thus, we can reasonably assume that the primary neurons
in culture studied here were mature and interconnected in a
functional network. Generation of the different genotypes was
obtained in the same litter by crossing PS2 heterozygous and PS1
floxed (PS2+/−; PS1flox/flox) animals, followed when necessary by
viral transduction of the Cre recombinase. This approach has
been used because although PS2 knockout (PS2−/−; PS2KO)
cells can be obtained from the viable PS2 full KO mice
(Herreman et al., 1999), PS1KO and PSdKO mice present a
lethal phenotype at E17 and E12, respectively (Shen et al.,
1997; Donoviel et al., 1999). Therefore, to obtain PS1KO and
PSdKO primary cultures, PSEN1 deletion was achieved by viral
transduction of Cre recombinase in PS1flox/flox primary cultures
(Figure 1A). Lentivirus expressing GFP (mock control) or CRE-
GFP were used at DIV1 (primary neurons) or at DIV17 (primary
astrocytes). Efficiency of infection was monitored by evaluating
GFP fluorescence intensity. Three days after infection, most cells
were GFP positive and GFP expression was maintained until the
day of the analysis. An example of GFP and CRE-GFP infected
neurons is shown in Supplementary Figure 1. We evaluated
the expression level of PS1 and PS2 by WB in neuronal and
astrocyte cultures (Figure 1B). Cre-mediated excision of PSEN1
was very efficient under these conditions, with 90% decrease
in PS1 expression when compared to mock-infected control
(Figure 1B). However, since a residual PS1 expression was still
observed after the infection, we consider the obtained cultures
as a model of PS1 knockdown (PS1KD). Given that APP is
a major substrate of the γ-secretase and critically involved in
AD, we evaluated by WB the accumulation of APP C-terminal
fragments (α-CTFs and β-CTFs) following PSs deletion. CTFs
are the direct substrates of the γ-secretase that accumulate when
γ-secretase activity is blocked. An important accumulation of
the CTFs (likely α-CTFs) was observed in PSdKO neurons and
astrocytes (Figures 1B,C). CTF accumulation is also observed in
PS1KD neuronal cultures, in line with the fact that PS1 is more
expressed in neurons than astrocytes (Lee et al., 1996; Lah et al.,
1997). The accumulation of CTFs is very low in the absence of
PS2 in primary neurons. This is in agreement with the fact that
PS2 only marginally contributes to APP processing when PS1
is present. To further characterize our model, we checked the
overall morphology of the various PS-deficient cells at DIV11
(neurons) and DIV24 (astrocytes) by immunostaining cells with
astrocytic (GFAP) and neuronal (MAP2) markers (Figure 2).
Protoplasmic astrocytes cultures were pure while some activated
astrocytes were present in neuronal cultures (±10%). There
were no apparent differences in terms of morphology or growth
between Ct, mock, PS1KD, PS2KO, and PSdKO cells.
Membrane Potential (19) and OXPHOS
Complexes Expression Are Not Affected in
PS-Deficient Primary Nerve Cells
As a primary indicator of mitochondrial mass (Whitaker-
Menezes et al., 2011), the expression level of the mitochondrial
import receptor subunit TOM20 (Figure 3A) was first evaluated
in cell lysates from primary neurons and astrocytes. No changes
were observed, suggesting that deletion of PSs did not affect the
mitochondrial mass in the cells tested. Mitochondrial membrane
potential (19) is crucial for energy production and it is
the driving force generated by the electron transport chain
(ETC) for ATP synthesis. 19 is known to stay stable since
its decrease is a strong indication signal of cell death (Uechi
et al., 2006). We evaluated the 19 with the TMRM probe
(Figure 3B), using FCCP (an uncoupling agent abolishing 19)
as a positive control. No significant differences in 19 were
observed between controls (Ct and Mock) and PS2KO, PS1KD,
and PSdKO cells, neither in neurons nor in astrocytes. Since ATP
synthase might work in reverse to keep 19 stable (Uechi et al.,
2006), a defect in ETC could still occur without being readily
detectable by mitochondrial membrane potential measurements.
We checked the expression of the ETC subunits by WB using a
cocktail of antibodies targeting representative subunits of the five
mitochondrial complexes (Figure 3C). We found no differences
in the expression of any ETC subunit in PS1KD, PS2KO, or
PSdKO neurons or astrocytes. This was rather unexpected since
we previously reported a defect in oxidative phosphorylation
(OXPHOS) capacity along with expression changes of the ETC
subunits in PS2KOMEF cell lines (Contino et al., 2017).
Mitochondrial Oxidative Phosphorylation
and Bioenergetics Are Not Affected by the
Absence of PS1 and/or PS2 in Primary
Neurons and Astrocytes
The absence of changes in ETC complexes levels is a biochemical
indication that does not rule out the hypothesis that OXPHOS
could be impaired in PS-deficient primary neurons or astrocytes.
Indeed, the cocktail of OXPHOS antibodies used in our study
targets only one subunit of each of the massive ETC complex.
We evaluated the activity of the ETC by measuring the overall
profile of oxygen consumption rate (OCR) and several related
parameters (Figures 4A–C). The parameters measured were
basal respiration, coupling (oxygen consumption devoted to
ATP synthesis under resting conditions), and spare respiratory
capacity (maximal uncoupled rate of respiration minus the
basal rate). The absence of PS2 affected all these parameters in
MEF PS2KO cell lines (Supplementary Figure 2). Strikingly, the
general OCR measured was similar in the presence (Ct, Mock)
or absence of PSs (PS1KD, PS2KO, PSdKO) in primary neurons
and astrocytes (Figures 4A–C). To note, the OCR at basal state
is running near the maximal respiratory capacity in astrocyte
cultures. This could suggest that the cells are stressed. However,
this kind of OCR profile is commonly observed in primary
astrocyte cultures (Damiano et al., 2014; Logan et al., 2018;
Neal et al., 2018). The GFAP staining (Figure 2) indicates that
astrocytes in culture are indeed activated astrocytes (Liddelow
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FIGURE 1 | Experimental workflow and model characterization in PS-defective primary nerve cells. (A) Workflow description of the experiments with specificity for
PSEN1 deletion. Primary neuronal and astrocyte cultures were performed on embryos at day 17 (E17) and postnatal pups at day 2 after birth (P2), respectively.
(Continued)
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FIGURE 1 | Generation of the different genotypes in the same litter were obtained from crossing PS2 heterozygous and PS1 floxed (PS2+/−; PS1flox/flox) animals
followed where necessary by viral transduction. At DIV1 for neurons and DIV17 for astrocytes, cells were either non-infected (Ct and PS2KO) or infected with GFP
(Mock) or CRE-GFP to induce PSEN1 gene deletion (PS1KD and PSdKO). Experiments were performed after 11 days for neurons and 24 days (including 7 days of
differentiation) for astrocytes. Ex2 and Ex3 = PSEN1 exons 2 and 3, respectively. (B,C) Representative WBs showing PS1 and PS2 expression profiles (left panel) and
APP C-terminal fragment (α-CTFs; right panel) in total cell lysates from primary neuronal (B) and astrocyte (C) cultures. Tubulin was used as loading control.
Quantification of PS1 expression (means ± sem) is given as percentage of signal measured in control cells (Mock); ****p < 0.0001; **p < 0.01; Student’s t-test for
neurons results and Mann-Whitney test for astrocytes results (N = 6).
FIGURE 2 | Morphology of PS-defective primary neuronal and astrocyte cultures. On the left side, a primary culture of neurons at DIV11 immuno-stained with
glial-specific protein GFAP (blue) and the neuron-specific protein MAP2 (red) antibodies. On the right side, a primary culture of astrocytes at DIV24 immuno-stained
with GFAP (blue) antibody. Scale bar = 100µm.
and Barres, 2017; Dubovy et al., 2018). This activated astrocyte
profile could explain the similar OCR values measured in
astrocytes at basal state and upon stimulation with FCCP.
The major outcome of genetic deletion of PSs is to down-
regulate or abolish γ-secretase activity in cells. Another way
to address the role of γ-secretase activity in OXPHOS is
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FIGURE 3 | 19 and OXPHOS complexes expression in PS-deficient primary nerve cells. Experiments were performed on primary DIV11 neuronal cultures and
primary DIV24 astrocytes cultures. Cell conditions were Ct vs. PS2KO, Mock (infection control) vs. PS1KD and PSdKO. (A) Representative WBs and quantifications of
TOM20 profile expression; in primary neuronal cell lysates (left panel) and in primary astrocyte cell lysates (right panel). Tubulin was used as a loading control. Results
(mean ± sem) are expressed as percentage of the respective control (ctr = Ct or Mock) (min N = 2). Kruskal–Wallis test and Dunn’s multiple comparison test. (B) 19
was evaluated with the TMRM probe in the presence or absence of FCCP, an uncoupling agent used as control (striped columns). Fluorescence signal was measured
(Continued)
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FIGURE 3 | with a plate reader and results are expressed as the percentage of the relative mean fluorescence of the respective control cells (ctr = Ct or Mock) (min N
= 3). ANOVA and Tukey’s multiple comparison test. ****p < 0.0001. (C) The expression level of representative protein subunits from each of the five mitochondrial
complexes (NDUFB8 for CI; SDHB for CII; UQCRC2 for CIII; MTCO1 for CIV; ATP5A for CV) was evaluated by WB on cell lysates. Actin was used as a loading control.
Dashed lines indicate that proteins were run on the same gel, but lanes are not contiguous. Quantifications of the different WBs (means ± sem) are given as
percentage of signal measured in the respective control cells (Ct or Mock) (min N = 3). ANOVA and Tukey’s multiple comparison test.
to block γ-secretase activity with pharmacological inhibitors.
To that end, we treated primary neurons and astrocytes for
24 h with 10µM of DAPT, a concentration that efficiently
blocks γ-secretase activity (Figure 5A). We measured the OCR
(Figures 5B,C) and observed no changes in DAPT-treated cells
when compared to non-treated cells. This confirms that γ-
secretase activity is not involved in OXPHOS, in agreement
with the results obtained in PS-deficient neurons and astrocytes.
We next measured the NAD+/NADH ratio (Figure 6A) and
glycolytic flux (Figure 6B), parameters related to bioenergetics.
NADH is an electron donor used by the first complex of the
ETC. Glycolysis can either produce intermediates for OXPHOS
or produce ATP and lactate depending on the oxidative status.
These parameters were found to be altered in PS2KO MEF cell
lines (Contino et al., 2017). We did not observe any changes
in these indicators in primary neurons or astrocytes in the
absence of PSs. In agreement, ATP levels were stable in all
cell types (Figure 6C). All these data strongly support that
the mitochondrial activity and related bioenergetics are not
dependent on PSs in neurons and astrocytes, on the contrary
to what was observed in MEF (Contino et al., 2017). Finally,
we checked for possible mitochondrial fusion/fission defects in
PS-deficient cells. Mitochondria are very dynamic entities and
their shape and length can change erratically due to fusion and
fission processes under certain circumstances such as cell division
or especially in response to stress. We evaluated by WB two
key proteins of mitochondrial fusion (OPA1) and fission (DRP1)
as indicators of altered mitochondrial dynamics (Figures 7A,B).
We found only a very small but significant increase in OPA1 in
PS2KO and PSdKO neurons that is not mirrored by the DRP1
profile. Thus, subtle changes in mitochondrial dynamics could
occur in PS2-deficient cells without affecting mitochondrial
OXPHOS and related bioenergetics (Figures 4, 5).
To further investigate the cellular effects of such protein
changes in PS2KO neurons, and since previous results
from our group demonstrated specific alterations in
mitochondrial function and content in immortalized PS2KO
MEF cells (Contino et al., 2017), we decided to evaluate
mitochondrial morphology in WT (Ct) and PS2KO neurons
by immunofluorescent staining against TOM20 (Figure 8A). A
semi-automated and detailed characterization was accomplished
by using the Mitochondrial Network Analysis (MiNA) toolset
in ImageJ, which allows the obtention of parameters to
quantitatively capture the morphology of the mitochondrial
network (Valente et al., 2017). Briefly, confocal images of mature
neurons (positive for MAP2) were processed to enhance their
resolution and converted to binary images, finally producing
the mitochondrial skeleton morphology. In all analyzed cells
mitochondria were interconnected, thus forming an intracellular
network, and no differences were observed when evaluating
the mean number of mitochondria (individuals: unbranched,
punctate organelles) or networks (branched, reticular structure
of fused mitochondria) (Figure 8B). Additionally, no differences
were observed in the mean number of junctions, end-points,
and slab voxels (data not shown), suggesting an unaltered shape
and distribution of the mitochondrial network together with the
same degree of network complexity between genotypes. Finally,
in order to confirm the lack of mitochondrial alterations in
PS2KO neurons, a RT-qPCR-based mtDNA content analysis was
performed in those cells, indicating normal mitochondrial mass
in response to PS2 depletion (Figure 8C).
Metabolic Characterization of PS2
Deficient Primary MEF
Since no metabolic defect was observed in primary neuronal and
astrocyte cells, we hypothesized that the phenotype previously
observed in MEF cells could be exclusively peripheral. Indeed,
the general OCR profile and related parameters were defective
in PS2KO MEF cell lines and restored after stable re-expression
of human PS2 (Supplementary Figure 2). To further investigate
this idea, we decided to generate primary MEF derived from
E16 WT (Ct) or PS2KO mice. We measured the expression
of TOM20 and subunits of OXPHOS complexes (Figure 9A)
and did not observe any differences between Ct and PS2KO
fibroblasts. The activity of the ETC was also stable in the
absence of PS2 as shown with the general OCR profile and
the related parameters (Figure 9B). Finally, NAD+/NADH ratio
and glycolytic flux (Figures 9C,D) were not modified either,
indicating ametabolic stability in primary fibroblasts lacking PS2.
The metabolic phenotype observed in primary fibroblasts is not
consistent with the one reported in immortalizedMEF, and could
reflect deep differences between primary and immortalized cells.
DISCUSSION
PSs play a major role in cell physiology and AD pathology as
catalytic subunits of the γ-secretase complex. The γ-secretase
is a multiprotein membrane complex, involved in regulated
intramembrane proteolysis (RIP). Up to 90 membrane proteins
have been identified as substrates of the γ-secretase (Haapasalo
and Kovacs, 2011). The major substrates are Notch and the
Amyloid Precursor Protein (APP), which respectively play a
critical role during development and in the amyloid pathology
found in AD (Hardy, 2006). PSs have also been implicated in
other cellular functions, including calcium homeostasis, cell-
cell adhesion, membrane trafficking, and Wnt signaling (Otto
et al., 2016). The most reported non-catalytic functions of PSs
are related to calcium homeostasis (Nelson et al., 2007; Cheung
et al., 2008; Wu et al., 2013). PSs contribute to the building
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FIGURE 4 | Assessment of the OXPHOS capacity in primary nerve cultures genetically deleted for PSs. Oxygen consumption rate (OCR) was evaluated by using the
Seahorse XF96 bioenergetic analyzer. Experiments were carried out in primary DIV11 neuronal cultures (left panel) and in primary DIV24 astrocyte cultures (right panel).
(Continued)
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FIGURE 4 | Cell conditions were wild-type non-infected (Ct) vs. PS2KO; control infection (Mock) vs. PS1KD and PSdKO. (A,C,E) General profile of the OCR with
vertical lines indicating the time point at which the different compounds have been added: a. Oligomycin (CV inhibitor) b. FCCP (19 uncoupler) c. Rotenone (CI
inhibitor) and antimycin A (CIII inhibitor). Values (means ± sem) are given in pmol O2/min/µg protein (min N = 3). (B,D,F) The basal respiration, the coupling ratio and
the spare respiratory capacity were calculated according to the Cell Mito Stress Test kit’s recommended protocol. Values (means ± sem) are given as percentage of
signal measured in the respective control cells (Ct or Mock) (min N = 3). ANOVA and Tukey’s multiple comparison test.
FIGURE 5 | Assessment of the OXPHOS capacity in primary nerve cultures treated with DAPT. OCR was evaluated by using the Seahorse XF96 bioenergetic
analyzer. Experiments were performed in primary neurons (DIV11) or primary astrocytes (DIV7) wild-type non-treated (NT or Ct) or treated with DAPT. (A) Accumulation
of α-CTF upon treatment with 10µM of DAPT for 24 h of control primary nerve cultures was evaluated by WB with an antibody targeting the C-terminal region of APP.
Tubulin was used as loading control. (B) General profile of the OCR with vertical lines indicate the time point at which the different compounds have been added: a.
Oligomycin (CV inhibitor) b. FCCP (19 uncoupler) c. Rotenone (CI inhibitor) and antimycin A (CIII inhibitor). Values (means ± sem) are given in pmol O2/min/µg protein
(N = 3). (C) The basal respiration, the coupling ratio, and the spare respiratory capacity were calculated according to the Cell Mito Stress Test kit’s recommended
protocol. Values (means ± sem) are given as percentage of signal measured in control cells (Ct). Student’s t-test for neurons results (N = 3) and Mann-Whitney test for
astrocytes results (N = 2).
of functional ER/mitochondria interfaces called mitochondria-
associated membranes (MAMs) (Area-Gomez et al., 2009;
Brunello et al., 2009; Filadi et al., 2016). MAMs control
calcium shuttling between ER andmitochondria, interconnecting
calcium homeostasis and mitochondrial function. We previously
observed in MEF cell lines that the absence of PS2 led to a
decrease in OXPHOS activity and in the expression of ETC
proteins, along with an increased anaerobic glycolysis that
sustains the ATP production. The effects observed were cell-
autonomous since defects in bioenergetics were rescued by the
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FIGURE 6 | Evaluation of ATP levels, NAD+/NADH ratio, and glycolytic flux in primary nerve cultures. Experiments were performed respectively at DIV11 and DIV24 in
neuronal (left panel) and astrocytes (right panel) cultures. Cell conditions were wild-type non-infected (Ct) vs. PS2KO; Mock (infection control) vs. PS1KD and PSdKO.
(ctr = Ct or Mock). (A) NAD+/NADH ratio was quantified by a bioluminescent kit (min N = 3). (B) Glycolysis rate was determined by the detritiation rate of [3-3H]
glucose after a 30min incubation. Data were normalized to protein content (min N = 3). (C) ATP level was quantified by a bioluminescent kit (min N = 3). ANOVA and
Tukey’s multiple comparison test.
stable expression of human PS2 in PS2KO cells (Contino et al.,
2017). These indications supported the role of presenilins, and
more precisely PS2 in mitochondrial function, in agreement
with other studies carried out in the same model (MEF) or in
neuronal cell lines. PS2 but not PS1 deficiency was reported
to alter mitochondrial respiration (Behbahani et al., 2006).
PS2 was found to modulate calcium shuttling between the ER
and mitochondria, a critical process for OXPHOS stimulation
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FIGURE 7 | Expression of mitochondrial fusion and fission proteins in PS-deficient primary nerve cells. Experiments were performed on primary DIV11 neuronal
cultures and primary DIV24 astrocytes cultures. Cell conditions were Ct vs. PS2KO, Mock (infection control) vs. PS1KD and PSdKO. (A) Representative WBs and
(Continued)
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FIGURE 7 | quantifications of DRP1 profile expression; in primary neuronal cell lysates (left panel) and in primary astrocyte cell lysates (right panel). Tubulin was used
as a loading control. Results (mean ± sem) are expressed as percentage of the respective control (ctr = Ct or Mock) (min N = 2). Kruskal–Wallis test and Dunn’s
multiple comparison test. (B) Representative WBs and quantifications of OPA1 profile expression; in primary neuronal cell lysates (left panel) and in primary astrocyte
cell lysates (right panel). Tubulin was used as a loading control. Results (mean ± sem) are expressed as percentage of the respective control (ctr = Ct or Mock) (min N
= 4). ANOVA and Tukey’s multiple comparison test, *p < 0.05.
and thereby mitochondrial activity (Zampese et al., 2011). In
agreement, a study reported that PSs are enriched in MAMs
(Area-Gomez et al., 2009).
We further investigated in this study the role of PSs in
mitochondrial function by using mouse primary neurons and
astrocytes. Contrary to what was previously observed, we found
that the absence of PS1 or PS2 and even of both (PSdKO)
did not affect mitochondrial ETC and related bioenergetic
parameters in primary nerve cells. Moreover, the morphology
of the mitochondrial network and the quantity of mtDNA were
not changed either in PS2KO neurons. Importantly, we also did
not observe any change in primary PS2-deficient fibroblasts, in
opposition to the results obtained in immortalized fibroblasts
(MEF cell lines). This raises important points about the
interpretation of the role of PSs inmitochondrial functions across
cellular models. First, the PS2KO MEF cell lines, which have
been widely used so far, can genetically derive and acquire clonal
properties, with the inherent risk of artifacts or misinterpretation
of the data (Kaur and Dufour, 2012). Immortalized cell lines
can acquire mutations with subcultures and these mutations
can interfere with the cellular phenotype. However, the rescue
experiments that we performed in a previous study indicated
that the mitochondrial defects observed in PS2KO MEF cell
lines are truly PS2-dependent (Contino et al., 2017). Second,
the immortalization process might be responsible for the PS2-
dependent phenotype observed in MEF. The fact that a PS2-
dependent phenotype is observed only in immortalized cells
can be related to data from the literature. PSs are involved
in different cellular pathways related to cancer, like Notch
and Wnt pathways (Xia et al., 2001; Andersson and Lendahl,
2014; Li et al., 2016). An increase in lung tumor formation
through peroxiredoxin 6 (PRDX6) activation was also reported
in PS2KO mice. The proposed underlying mechanism involves
the PS2-dependent γ-secretase cleavage of PRDX6 that inhibits
its critical activity in cell growth (Yun et al., 2014; Park et al.,
2017). Another study showed that PSs are involved in epidermal
growth and transformation by regulating the epidermal growth
factor receptor (EGFR) signaling (Rocher-Ros et al., 2010). It
is also important to take into account that the immortalization
process used for the generation of MEF cell lines relied on SV40
Antigen T expression (De Strooper et al., 1999), which shows
similarities with tumor development due to the large T antigen
forming complexes with pRB-1 and p53 (Hubbard and Ozer,
1999; Pipas, 2009). In agreement, the inhibition of γ-secretase
activity is suggested as a potential approach for cancer treatment.
Interestingly, PSs have been associated to regulation of proteins
such as Akt, HIFα, or β-catenin (Xia et al., 2001; Kang et al.,
2005; De Gasperi et al., 2010). Those proteins contribute to
the Warburg effect, which states that most cancer cells produce
lactic acid from glucose even under non-hypoxic conditions and
despite functional mitochondria (Koppenol et al., 2011). Many
pieces of evidence relate thus PSs function to cancer processes,
not only to neurodegenerative diseases. Our data clearly indicate
that the absence of PS2 has a different outcome when measured
in primary fibroblast or in immortalized fibroblast. The large
amount of data reported so far inMEF cell lines (Behbahani et al.,
2006; Tu et al., 2006; Brunello et al., 2009; Filadi et al., 2016;
Pera et al., 2017) might be relevant to describe the role of PSs
and γ-secretase activity in cancer models, which are difficult to
transpose to a neurodegenerative context.
To that end, we addressed the role of PSs in mitochondrial
function in primary neurons and astrocytes. Neurons are a prime
target of neurodegeneration, and a major function of astrocytes
is to support neuronal activity. Impairment of the neuronal
network and activity underlies the gradual memory and other
cognitive deficits in AD (Long and Holtzman, 2019). Although
neurons are themost studied nerve cell type, astrocytes also play a
key role in AD pathogenesis (Verkhratsky et al., 2010). Astrocytes
and neurons are known to be metabolically different. Neurons
rely primarily on mitochondrial oxidative phosphorylation for
energetic supply and astrocytes on glycolysis. We did not
observe any metabolic defects in our PS-deficient primary
neuronal cultures. Indeed, the OXPHOS system (activity and
expression) as well as the 19 , glycolysis, and NAD+/NADH
ratio were comparable between control, PS2KO, PS1KD, and
PSdKO cells. Since astrocytes are more glycolytic than neurons
(Kasischke et al., 2004; Castelli et al., 2019), we hypothesized
that astrocytes would be close, in terms of metabolic phenotype,
to the MEF cell line we previously analyzed (Contino et al.,
2017). However, all the metabolic parameters evaluated in
primary astrocytes were not altered by the absence of PSs.
This leads us to conclude that the lack of PSs does not
affect neither the OXPHOS, nor related metabolic aspects,
such as glycolysis and NAD+/NADH ratio in primary nerve
cells. In support of these observations, the analysis of the
morphology and complexity of the mitochondrial network, as
well as its mass, does not show differences between control
and PS-deficient neurons. This result is coherent with all
the data obtained regarding mitochondrial function; indeed,
the preservation of a correct and interconnected network of
mitochondria is crucial to cell function (Chen and Chan,
2004; Lackner, 2014). To note, differences between nerve cells
and peripheral cells have been reported in a metabolic study
comparing primary neurons, astrocytes, and fibroblasts cultures
deficient for the mitochondrial complex I subunit NDUFS4,
a model for the mitochondrial Leigh syndrome, a severe
neurological disease (Bird et al., 2014). The 19 and ATP
synthesis were impaired in the NDUFS4 KO primary MEF, with
an increase in ROS generation and an altered sensitivity to cell
death. In contrast, NDUFS4 KO primary neurons and astrocytes
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FIGURE 8 | Evaluation of mitochondrial morphology and content in PS2KO neurons. (A) Mitochondria from wild-type non-infected (Ct) and PS2KO neurons at DIV11
were stained with an anti-TOM20 antibody (green) and mature neurons were identified with MAP2 (red). Confocal microscope images were acquired and TOM20
images were processed using the MiNA toolset to generate accurate mitochondrial skeletons for further analysis. Scale bar = 20µm. (B) Quantification of individuals
(counts) and networks (counts) are shown in the graphs. Results are presented as mean ± sem. Student’s t-test (n = 55 from N = 3 independent experiments). (C)
RT-qPCR analysis of mitochondrial DNA content (Cyt-b and Nd1 mitochondrial genes) in wild-type non-infected (Ct) and PS2KO neurons at DIV11. Results (mean ±
sem) are expressed as percentage of the respective control (Ct) (min N = 4).
displayed only impaired ATP generation. This underlines the
importance of the cellular model and experimental set-up when
investigating alteration of mitochondrial function related to a
neuronal pathology.
Still, the fact that the absence of PSs does not affect the basal
mitochondrial-related bioenergetics in astrocytes and neurons
is rather intriguing. Considering the expression profiles of the
PSEN1 and PSEN2 genes throughout the body, one could
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FIGURE 9 | Metabolic characterization of PS2 deficient primary MEF. Experiments were carried out in primary MEF derived from E16 WT mice (Ct) or PS2KO mice
(PS2KO). (A) Expression profile of PS2 (left panel, up), TOM20 (left panel, down), and representative protein subunits from each of the five mitochondrial complexes
(right panel; NDUFB8 for CI; SDHB for CII; UQCRC2 for CIII; MTCO1 for CIV; ATP5A for CV), evaluated by WB on cell lysates. Actin was used as a loading control.
Quantifications of the different WBs (means ± sem) are given as percentage of signal measured in control cells (Ct) (min N = 3). Student’s t-test. (B) Left panel:
General OCR profile of primary MEF Ct vs. PS2KO. Values (means ± sem) are given in pmol O2/min/µg protein. Right panel: The basal respiration, the coupling ratio
and the spare respiratory capacity. Values (means ± sem) are given as percentage of signal measured in control cells (Ct) (N = 3). (C) NAD+/NADH ratio was
quantified by a bioluminescent kit (N = 4). (D) Glycolytic rate was determined by the detritiation rate of [3-3H] glucose after a 30min incubation. Data were normalized
to protein content (N = 3). Student’s t-test.
expect to have distinct phenotypes related either to PS1 or PS2
deficiency. PS1 was suggested to be more important in CNS
and PS2 in peripheral organs (Lee et al., 1996). The absence
of mitochondrial defects in PSdKO is even more unexpected,
considering the broad array of functions attributed to PSs (Zhang
et al., 2013; Wolfe, 2019), which process more than 90 membrane
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proteins (Haapasalo and Kovacs, 2011; Wolfe, 2019). Cortical
brain sections from conditional PSdKO mice show several
pathological features such as neurodegeneration, astrogliosis, and
even swollen mitochondria (Saura et al., 2004; Wines-Samuelson
et al., 2010). The experimental set-up and environment should
be taken into consideration to give a precise interpretation to
data obtained across different models. All our experiments were
performed on primary cells that were cultured in low glucose
(5mM) medium, to reflect a more physiological condition.
Neurons and astrocytes were mature and differentiated (DIV11
for neurons and DIV24 for astrocytes), and tested at basal and
resting state. Challenging the cells might be a key point for further
investigations to unravel a deficit that could be masked in basal
conditions. The time of the culture, especially for neurons, is also
an important parameter. Performing the experiments on aged
cultures would be of interest to check if mitochondrial functions
evolves distinctly in PS-deficient cells upon aging. Cultures
could be supplied with different types of cell fuels (pyruvate,
fatty acid. . . ), cells could be challenged with depolarization or
hypoxia to perhaps unravel a PS-dependent phenotype in specific
contexts. Indeed, the brain tissue is much more complex than in
vitro cultures, in which disrupted PS-dependent cell interactions
could account for changes in energy homeostasis (Saura et al.,
2004; Wines-Samuelson et al., 2010).
In conclusion, our study provides evidence for the lack of
mitochondrial alterations in PS1KD, PS2KO, and even PSdKO
neurons and astrocytes, as well as in PS2KO primary MEF.
This is in contradiction with previous observations in neuronal
cell lines and immortalized fibroblasts. Thus, immortalized
cells might provide relevant results regarding the role of PSs
in mitochondrial activity and bioenergetics related to cancer
processes, in which PSs involvement have already been reported.
However, the contribution of PSs to alterations in mitochondrial
activity related to neurodegenerative processes, such as AD, needs
to be critically readdressed and further explored in brain models.
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